Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

Author's Avatar
Aug 25, 2022

Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).